For your amusement: The latest definitive "Deep Dive"
Sarepta Therapeutics (NASDAQ: SRPT)
Oct 2, 2022
"Sarepta Therapeutics (NASDAQ:SRPT) was founded by Marwan Fawaz in 1980 with the mission of developing precision genetic medicines for the treatment of rare neuromuscular diseases.
Fast forward to 2022 and Sarepta Therapeutics is a pioneer in Duchenne ..."